PledPharma AB | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
49,302.00
100,043.00
50,360.00
393,998.00
309,531.00
Total Accounts Receivable
1,226.00
2,943.00
963.00
1,602.00
4,001.00
Other Current Assets
428.00
430.00
1,038.00
1,093.00
1,836.00
Total Current Assets
50,956.00
103,416.00
52,361.00
396,693.00
315,368.00
Net Property, Plant & Equipment
5.00
2.00
-
-
-
Total Investments and Advances
50.00
50.00
-
-
-
Total Assets
51,011.00
103,468.00
52,361.00
396,693.00
315,368.00
Accounts Payable
1,278.00
9,967.00
1,766.00
4,678.00
5,972.00
Other Current Liabilities
2,779.00
2,843.00
2,563.00
2,453.00
5,685.00
Total Current Liabilities
4,057.00
12,810.00
4,329.00
7,131.00
11,657.00
Total Liabilities
4,057.00
12,810.00
4,329.00
7,131.00
11,657.00
Common Equity (Total)
46,954.00
90,658.00
48,032.00
389,562.00
303,711.00
Total Shareholders' Equity
46,954.00
90,658.00
48,032.00
389,562.00
303,711.00
Total Equity
46,954.00
90,658.00
48,032.00
389,562.00
303,711.00
Liabilities & Shareholders' Equity
51,011.00
103,468.00
52,361.00
396,693.00
315,368.00

About PledPharma AB

View Profile
Address
Grev Turegatan 11C
Stockholm AB 114 46
Sweden
Employees -
Website http://www.pledpharma.se
Updated 09/14/2018
PledPharma AB operates as a pharmaceutical company, which engages in the development of new drugs that protect the body against oxidative stress, a potentially disabling and sometimes life-threatening condition that can be caused by chemotherapy treatment and acetaminophen (paracetamol) poisoning. It offers the PledOx which reduces nerve damage associated with chemotherapy. The company was founded by Torsten Almén, Heidi Brurok, Louis J.